Development of new indicators for the launch of a Japanese version of the NIH (5) : Analysis based on refined indicators for patents linked with marketed drugs and pipelines

Abstract

For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried to give an overview and future prospects of pharmaceutical industry based on new indicators. Here we show the trends of very basic research of small molecule drug and bio-medicine by country, patents assignees, using new indicators for identifying patents related with pharmaceutical entities' marketed drugs and pipelines.